Inner Ear Gene Therapy: An Overview from Bench to Bedside.

Area of Science:

• Otolaryngology
• Genetics
• Regenerative Medicine

Background:

• Hearing loss is a widespread sensory disorder, with genetic mutations being a primary cause of congenital cases.
• Current treatments for hearing loss are limited to hearing aids and auditory implants.
• Recent advances in research have led to the development of gene therapy strategies for hearing loss.

Purpose of the Study:

• To provide an overview of genetic hearing loss and inner ear gene therapy research.
• To summarize findings from completed and ongoing clinical trials.
• To discuss future challenges for the clinical application of inner ear gene therapy.

Main Methods:

• Review of current literature on genetic hearing loss.
• Analysis of animal models for inner ear gene therapy.
• Summarization of data from clinical trials.

Main Results:

• Gene therapy has shown significant hearing improvement in patients in early clinical trials.
• Various gene therapy strategies have been established in animal models.
• Ongoing clinical trials are providing novel findings on treatment efficacy.

Conclusions:

• Gene therapy is a promising treatment for specific forms of genetic hearing loss.
• Further research and overcoming hurdles are necessary for broad and safe clinical application.
• Inner ear gene therapy holds potential to revolutionize hearing loss treatment.